Answers are grounded in this paper and cite their sources.
Since 1990, the Developmental Therapeutics Program (DTP) of the National Cancer Institute (NCI) has screened over 60 000 compounds and a larger number of natural product extracts for their capacity to inhibit the growth of 60 different human tumor cell lines (1). These cell lines have been maintained in cryopreservation and in culture, and they have been subjected to strict quality controls, including adventitious agent testing, human isoenzyme analysis, karyology, morphological and immunocytochemical characterization (2), and DNA fingerprinting. One of these cell lines, previously designated as MCF-7RES, has been included in the in vitro cell line screening panel because of its stable multidrug-resistant (MDR) phenotype (3) characterized by high levels of MDR-1 and P-glycoprotein expression (4,5). Recently, we submitted cell lines from the screening panel for DNA fingerprinting analysis by three different laboratories. Included in the tested cell lines were MCF-7 and MCF-7RES. Utilizing restriction fragment length polymorphism (RFLP) testing, CellMark Diagnostics (Germantown, MD) concluded that their DNA fingerprinting data were consistent with each of the cell lines (MCF-7 and MCF-7RES) having different donors. The other laboratories— American Type Culture Collection (Rockville, MD) used both RFLP and amplification fragment length polymorphism (AmpFLP) methods, and Children'ss Hospital of Michigan Cell Culture Laboratory (Detroit, MI) used the AmpFLP method— reached the same conclusions. Based on the reports from these DNA fingerprinting analyses, we have concluded that the preponderance of the information available suggests that the MCF-7RES multidrug-resistant cell line that is in cluded in the DTP screening program is not related to the MCF-7 cell line that is a part of the screening panel. Thus, we have changed the nomenclature of the MCF-7RES multidrug-resistant cell line. The new designation of this cell line is NCIRES. This nomenclature change will soon appear in all DTP databases, including the worldwide web. The DTP web site address is: http:\1.ncifcrf.gov:2345d.html Irrespective of its origin, this cell line has served as a valuable sentinel for compounds interacting with the multidrug-resistant mechanism (5).
No takes yet. Share an insight, caveat, or question.
Scudiero et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: